Global Oral Contraceptive Pills Market to Reach US$22.9 Bn by 2023 Owing to Rise in Unintended Pregnancies
Oral contraceptive pills are used for birth control and are also known as combined oral contraceptive pills or combined pills. Oral contraceptive pills are available on the market in five dosage options, the 21-day pack, the 24-day pack, the 28-day pack, the 91-day pack, and the four-phase regimen. In the 91-day pack segment, 'Seasonable' from Barr Laboratories and 'Seasonique' from Teva Pharmaceutical Industries are popularly used. 'Natazia' from Bayer AG leads the four-phase regimen whereas 'Yaz' and 'Loestrin' lead the...
View full press release